Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37850

HINT3 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

HINT3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited population in HEK293T cells for loss-of-function studies of HINT3, a mitochondrial phosphoramidase. HINT3 operates in the p53 pathway, influencing mitochondrial permeability and cytochrome c release to regulate CASP9/CASP3 apoptotic signaling through TRAP1, PPIF, and SLC25A4 interactions. The model supports research into mitochondrial nucleotide metabolism, p53-dependent apoptosis, and cancer drug targets. Key assays include Western blotting, JC-1 staining, and cytochrome c release assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    HINT3

    Gene Identifier

    NCBI Gene ID 135114

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

HINT3 Knockout HEK293T Polyclonal Cells represent a heterogeneous population of HEK293T cells engineered via CRISPR/Cas9-mediated gene disruption to eliminate functional HINT3 expression. This polyclonal knockout product provides a genetically mixed pool of edited cells, allowing researchers to assess the overall impact of HINT3 loss without clonal selection biases. The CRISPR/Cas9 approach introduces targeted disruptions in the HINT3 locus, generating a versatile loss-of-function model for studying mitochondrial nucleotide metabolism and apoptosis.

The HEK293T cell line is a widely used human embryonic kidney epithelial cell model, stably transformed with SV40 large T antigen to enhance episomal replication and protein expression. These adherent cells, derived from a female donor, are renowned for their high transfectability and utility in viral vector production. The renal epithelial origin of HEK293T cells makes them a valuable system for investigating kidney-related cellular processes, while their robust growth and manipulation ease support diverse experimental workflows.

HINT3 encodes a mitochondrial adenosine 5??-monophosphoramidase that hydrolyzes nucleotide phosphoramidate bonds, serving as a regulator of mitochondrial nucleotide metabolism. Under cellular stress, TP53 (p53) activates HINT3 transcription, positioning it within the intrinsic apoptosis pathway. HINT3 modulates mitochondrial membrane permeability and cytochrome c (CYCS) release through interactions with TRAP1, PPIF (cyclophilin D), and SLC25A4 (ANT1), key components of the mitochondrial permeability transition pore (mPTP). This activity influences the activation of CASP9 and CASP3, thereby regulating caspase-dependent apoptosis.

Disruption of HINT3 in HEK293T cells provides a powerful tool to dissect the molecular determinants of mitochondrial-mediated apoptosis and p53-dependent cell death. Given the central role of p53 in cancer biology and response to genotoxic stress, HINT3 knockout cells enable detailed investigation of how nucleotide phosphoramidate metabolism influences apoptotic sensitivity. The HEK293T background, with its well-characterized signaling networks and ease of genetic manipulation, facilitates rescue experiments, pathway reconstitution, and drug-response profiling. This model is particularly relevant for studying mitochondrial dysfunction disorders and oncogenic stress responses.

Researchers can use HINT3 knockout HEK293T polyclonal cells in diverse assays to study mitochondrial nucleotide metabolism and apoptosis. Western blotting and RT-qPCR confirm knockout and downstream target expression; immunofluorescence and JC-1 staining assess mitochondrial membrane potential; Annexin V and cytochrome c release assays quantify apoptosis. Co-immunoprecipitation and LC-MS nucleotide profiling define HINT3 interactors and metabolic alterations. This model enables drug target discovery and mechanistic studies of p53-dependent cell death. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)